Batten Disease Treatment Market: By Type Of Disease, Infantile NCL, Late infant NCL, Adult NCL, Others), By Treatment, By Distribution Channel and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Batten Disease Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type Of Disease (Juvenile NCL (JNCL), Infantile NCL (INCL), Late infant NCL (LINCL), Adult NCL, Others), By Treatment (Gene Therapy, Drug Therapy, Enzyme Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Batten Disease Treatment Market size was valued at US$ 38.8 million in 2023 and is poised to grow at a CAGR of 5.4% from 2024-2030. The global market provides a detailed overview and which can be segmented by type of disease, treatment, distribution channel, and region. By type of disease, the market has been segmented into juvenile NCL (JNCL), infantile NCL (INCL), late infant NCL (LINCL), adult NCL, and others. By treatment, the adult NCL segment held the largest revenue share of the batten disease treatment market in historic years and is expected to have a significant growth rate over the forecasted period due to the rising adult population suffering from batten disease. By treatment, the has been segmented into gene therapy, drug therapy, enzyme therapy, and others.

By treatment, the drug therapy segment held the maximum revenue share of the batten disease treatment market and is anticipated to have a significant growth rate during the forecasted period due to continuous advancement in drug therapy by increasing investment in the healthcare system. By distribution channel, the batten disease treatment market has been segmented into hospital pharmacies, retail pharmacies, and others. By treatment type, the hospital segment held the largest revenue share of the batten disease treatment market in past years and is expected to have the fastest growth rate over the forecasted period due to a high patient population proportion worldwide.  

Batten Disease Treatment Market Key Development:

  • In June 2021  Neurogene Inc., a company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its adeno-associated virus (AAV) encoding a codon-optimized human CLN5 transgene (hCLN5) for patients diagnosed with CLN5, a subtype of Batten disease.

summary download arrow Download Free Sample

Batten Disease Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.4%

Largest Market

North America

Fastest Growing Market

North America

Batten Disease Treatment Market Dynamics

Increase in the incidence of neurological disorders, and also a rise in the investment of biotechnology and pharmaceutical industries in research and development is further expected the growth of the batten disease treatment market. Moreover, the increasing demand for better treatment methods is further estimated to boosting the growth of the batten disease treatment market. Apart from this, the presence of fewer drugs accepted for batten disease is further projected to obstruct the growth of the batten disease treatment market in the timeline period.

Batten Disease Treatment Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 38.8 million

Market CAGR

5.4%

By Type of Disease

  • Juvenile NCL (JNCL)
  • Infantile NCL (INCL)
  • Late infant NCL (LINCL)
  • Adult NCL
  • Others

By Treatment

  • Gene Therapy
  • Drug Therapy
  • Enzyme Therapy
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global batten disease treatment market size was valued at US$ 38.8 million in 2023 and is projected to grow at a CAGR of 5.4% from 2024–2030.

The major factors driving the market growth are the rising incidence of neurological disorders, and also a rise in the investment of biotechnology and pharmaceutical industries in research and development, and the launch & adoption of several drugs for the treatment of the batten disease treatment market.

Huge investment in healthcare systems and acquisition are the two key strategies opted for by the leading companies in the market.

The Healthcare system is getting huge support from the government around the globe. Cohesive policies and government support improved the healthcare system of the world. For instance, the US spends over $10,000 per individual, which is the highest healthcare spending across the world. Other developed economies such as the UK, Germany, and Canada, among others, inject a significant amount of money into the healthcare system. Even emerging economies including China, Korea, India, Korea, and Thailand are also increasing their healthcare spending.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Batten Disease Treatment Market Introduction 
2.1.Global Batten Disease Treatment Market  - Taxonomy
2.2.Global Batten Disease Treatment Market  - Definitions
2.2.1.Type of Disease
2.2.2.Treatment
2.2.3.Distribution Channel
2.2.4.Region
3.Global Batten Disease Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Batten Disease Treatment Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Batten Disease Treatment Market  By Type of Disease, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Juvenile NCL (JNCL)
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Infantile NCL (INCL)
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Late infant NCL (LINCL)
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Adult NCL
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Batten Disease Treatment Market  By Treatment, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Gene Therapy
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Drug Therapy
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Enzyme Therapy
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Batten Disease Treatment Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Batten Disease Treatment Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Batten Disease Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type of Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Juvenile NCL (JNCL)
9.1.2.Infantile NCL (INCL)
9.1.3.Late infant NCL (LINCL)
9.1.4.Adult NCL
9.1.5.Others
9.2.  Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Gene Therapy
9.2.2.Drug Therapy
9.2.3.Enzyme Therapy
9.2.4.Others
9.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacies
9.3.2.Retail Pharmacies
9.3.3.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Batten Disease Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type of Disease Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Juvenile NCL (JNCL)
10.1.2.Infantile NCL (INCL)
10.1.3.Late infant NCL (LINCL)
10.1.4.Adult NCL
10.1.5.Others
10.2.  Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Gene Therapy
10.2.2.Drug Therapy
10.2.3.Enzyme Therapy
10.2.4.Others
10.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Retail Pharmacies
10.3.3.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11.Asia Pacific (APAC) Batten Disease Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type of Disease Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Juvenile NCL (JNCL)
11.1.2.Infantile NCL (INCL)
11.1.3.Late infant NCL (LINCL)
11.1.4.Adult NCL
11.1.5.Others
11.2.  Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Gene Therapy
11.2.2.Drug Therapy
11.2.3.Enzyme Therapy
11.2.4.Others
11.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Retail Pharmacies
11.3.3.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Batten Disease Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type of Disease Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Juvenile NCL (JNCL)
12.1.2.Infantile NCL (INCL)
12.1.3.Late infant NCL (LINCL)
12.1.4.Adult NCL
12.1.5.Others
12.2.  Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Gene Therapy
12.2.2.Drug Therapy
12.2.3.Enzyme Therapy
12.2.4.Others
12.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Retail Pharmacies
12.3.3.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Batten Disease Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type of Disease Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Juvenile NCL (JNCL)
13.1.2.Infantile NCL (INCL)
13.1.3.Late infant NCL (LINCL)
13.1.4.Adult NCL
13.1.5.Others
13.2.  Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Gene Therapy
13.2.2.Drug Therapy
13.2.3.Enzyme Therapy
13.2.4.Others
13.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Retail Pharmacies
13.3.3.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Abeona Therapeutics Inc. (U.S.)
14.2.2.BioMarin Pharmaceutical Inc. (U.S.)
14.2.3.CereSpir Inc. (U.S.)
14.2.4.Evotec AG (Germany)
14.2.5.Ionis Pharmaceuticals Inc. (U.S.)
14.2.6.Mitochon Pharmaceuticals Inc. (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Abeona Therapeutics Inc. (U.S.)
  • BioMarin Pharmaceutical Inc. (U.S.)
  • CereSpir Inc. (U.S.)
  • Evotec AG (Germany)
  • Ionis Pharmaceuticals Inc. (U.S.)
  • Mitochon Pharmaceuticals Inc. (U.S.)
  • Spark Therapeutics Inc. (U.S.)

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market